Identificación de factor de crecimiento vascular endotelial en células glandulares de tejido prostético maligno y benigno: Relación con la recidiva tumoral al año de la prostatectomía
Autor: | Felipe Cardemil, Pedro Acuña, Andrés Ellwanger, Renato Casalino, Angela Ramírez, Jorge Vega, Eva Madrid |
---|---|
Rok vydání: | 2013 |
Předmět: |
Pathology
medicine.medical_specialty medicine.diagnostic_test Prostatectomy business.industry medicine.medical_treatment Cancer General Medicine Hyperplasia medicine.disease Prostate-specific antigen Vascular endothelial growth factor chemistry.chemical_compound Prostate cancer Vascular endothelial growth factors chemistry Biopsy medicine Immunohistochemistry Prostatic neoplasms business Prostatic hyperplasia |
Zdroj: | Revista médica de Chile v.141 n.2 2013 SciELO Chile CONICYT Chile instacron:CONICYT |
ISSN: | 0034-9887 |
DOI: | 10.4067/s0034-98872013000200002 |
Popis: | 72 544x376 Normal 0 21 false false false Normal 0 21 false false false ES X-NONE X-NONE MicrosoftInternetExplorer4 VASCULAR ENDOTHELIAL GROWTH FACTOR IN MALIGNANT AND NON MALIGNANT PROSTATIC TISSUE. ASSOCIATION WITH TUMOR RECURRENCE AT ONE YEAR AFTER PROSTATECTOMY. Background : Prostate cancer (PC) is the second cause of death by cancer in men in Chile. Its behavior is so variable that it is necessary to search reliable prognostic markers. Vascular Endothelial Growth Factor (VEGF) is one of the most powerful pro-angiogenic factors. There is no agreement on its validity as a diagnostic or prognostic factor. Aim : To search for VEFG in prostatic tissue. Material and Methods : This study was performed in prostatectomy tissue coming from 41 patients with PC and 39 patients with benign prostatic hyperplasia (BPH). Specimens were studied using immunohistochemical staining for VEGF. The percentage of stained glandular cells per patient was calculated and associated with pathological diagnosis in cancer patients. Results: PC biopsies had a mean of 82% of VEGF (+) stained cells, while BPH had only 1.6% (p Conclusions : These results would rule out VEGF as a prognostic factor in this series of patients. /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Tabla normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0cm; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;} |
Databáze: | OpenAIRE |
Externí odkaz: |